Hippiron (Canada)

Company: Zoetis

IRON SUCROSE INJECTION USP (20 mg/mL)

DIN 00719021

Veterinary Use Only

Sterile

Active ingredients per mL: Iron (as ferric hydroxide-sucrose complex) 20 mg

Warnings

Keep out of reach of children. This drug is not to be administered to horses that are to be slaughtered for use in food.

Hippiron Indications

As an aid in the treatment of iron deficiency in horses (equine anaemia).

Dosage and Administration

Weaned foals and yearlings: 5 mL per 100 kg bodyweight.

Adult horses: 10 mL per 100 kg bodyweight.

By slow intravenous injection directly into the jugular vein, using aseptic technique.

CAUTIONS: Do not exceed recommended dosage. If clinical signs of iron deficiency persist, consult a veterinarian.

ADVERSE EVENTS: Anaphylactic reactions have been reported with the use of this product. If an allergic reaction occurs, administer epinephrine, cortisone or antihistamine immediately, as indicated.

Storage

Store between 15 and 25°C. Protect from light. Do not refrigerate.

Hippiron^® is a registered trademark of CZ Veterinaria; Zoetis Canada Inc. is duly authorized to use the trademark for the purpose of marketing, selling and distributing the product in Canada

Manufactured by: CZ Veterinaria, S.A., 36410 Porriño Spain

Distributed by: Zoetis Canada Inc., Kirkland QC H9H 4M7

CPN: 1198576.1